3/31
12:33 pm
bcax
Rating for BCAX
Medium
Report
Rating for BCAX
3/31
12:33 pm
bcax
Rating for BCAX
Medium
Report
Rating for BCAX
3/31
12:33 pm
bcax
Rating for BCAX
Medium
Report
Rating for BCAX
3/31
10:20 am
bcax
Bicara Therapeutics (BCAX) had its "outperform" rating reaffirmed by Wedbush. They now have a $30.00 price target on the stock.
Low
Report
Bicara Therapeutics (BCAX) had its "outperform" rating reaffirmed by Wedbush. They now have a $30.00 price target on the stock.
3/31
10:20 am
bcax
Bicara Therapeutics (BCAX) had its "outperform" rating reaffirmed by Wedbush. They now have a $30.00 price target on the stock.
Low
Report
Bicara Therapeutics (BCAX) had its "outperform" rating reaffirmed by Wedbush. They now have a $30.00 price target on the stock.
3/31
10:05 am
bcax
Rating for BCAX
Low
Report
Rating for BCAX
3/31
10:05 am
bcax
Rating for BCAX
Low
Report
Rating for BCAX
3/31
09:52 am
bcax
Rating for BCAX
Medium
Report
Rating for BCAX
3/31
09:52 am
bcax
Rating for BCAX
Medium
Report
Rating for BCAX
3/25
08:42 am
bcax
Bicara Therapeutics (BCAX) is now covered by Bank of America Corporation. They set a "buy" rating and a $35.00 price target on the stock.
Low
Report
Bicara Therapeutics (BCAX) is now covered by Bank of America Corporation. They set a "buy" rating and a $35.00 price target on the stock.
1/29
06:10 am
bcax
Bicara Therapeutics (NASDAQ:BCAX) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.
Low
Report
Bicara Therapeutics (NASDAQ:BCAX) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.